LATEST NEWS
December 13, 2024 | Company Announcements
New Incentive Program Established for Members of Executive Management and Selected Employees in Bavarian Nordic December 11, 2024 | Company Announcements
Bavarian Nordic to Launch DKK 150 Million Share Buy-back ProgramNovember 29, 2024 | Company Announcements
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant ExerciseNovember 15, 2024 | Company Announcements
Bavarian Nordic Announces Interim Results for the First Nine Months of 2024October 29, 2024 | Press Releases
First Children Vaccinated in New Clinical Study Seeking to Expand the Indication for Bavarian Nordic’s Mpox Vaccine September 26, 2024 | Company Announcements
Bavarian Nordic Upgrades its Financial Guidance for 2024September 26, 2024 | Company Announcements
Bavarian Nordic Signs Agreement with UNICEF for 1 Million Mpox Vaccines September 24, 2024 | Company Announcements
Bavarian Nordic Awarded USD 63 Million from the U.S. Government for Production and Supply of Additional Smallpox/Mpox Vaccines September 19, 2024 | Press Releases
Bavarian Nordic Receives EMA Approval of Mpox Vaccine for AdolescentsSeptember 18, 2024 | Company Announcements
Gavi Signs Agreement with Bavarian Nordic to Rapidly Secure 500,000 Doses of Mpox Vaccines for Africa